Skip to main content
Clinical Trials/NCT03288194
NCT03288194CompletedNot Applicable

Improving Quality of Life in Outpatients With Heart Failure: A Two-arm Randomized Controlled Trial

University of Colorado, Denver1 site in 1 country14 target enrollmentStarted: October 1, 2015Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
14
Locations
1
Primary Endpoint
Change in Kansas City Cardiomyopathy Questionnaire

Study Overview

Brief Summary

This research study has been designed to test the efficacy of telephone-delivered Problem-Solving Treatment (PST) for improving the quality of life (QoL) in outpatients with stable heart failure (HF).

Detailed Description

Heart failure (HF) is the end stage of all cardiovascular diseases, and it imposes a huge burden in the United States in terms of morbidity, mortality, and economic cost. Although disease management programs have been developed to curb these costs and address the complexities of HF management, evaluations of these programs have yielded equivocal results.

With this study the Investigators plan to: (1) to determine the feasibility of telephone delivered PST for outpatients with HF and reduced QoL by obtaining estimates of yield, retention, patient acceptance, and patient satisfaction; (2) to determine whether telephone-delivered PST is associated with greater improvements in QoL than telephone-delivered Time Management over 8 weeks; and (3) to determine whether telephone-delivered PST is associated with greater reductions in depressive symptoms and/or greater improvements in self-efficacy or objectively assessed daily physical activity than telephone-delivered Time Management over 8 weeks.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
21 Years to 99 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Outpatient
  • Age > 21
  • Exhibits symptoms of hear failure (NYHA Class II or III)
  • Left ventricular ejection fraction (LVEF) >= 40%
  • Kansas City Cardiomyopathy Questionnaire (KCCQ) summary score < 60

Exclusion Criteria

  • Cannot speak English
  • Lack telephone access
  • Unwilling to be randomized, or
  • Unavailable for the study period
  • Awaiting a heart transplant (United Network for Organ Sharing Status 1A or 1B), or
  • Planned (within 6 months) cardiac surgery
  • Cognitive impairment indicative of dementia
  • Recent (3 months)
  • acute myocardial infarction,
  • cardiac decompensation, or
  • HF-related hospitalization.
  • Use intravenous inotropic medication
  • Use an assistive circulatory device
  • Significantly reduced life expectancy due to co-morbidity (e.g., malignancy)
  • Currently receiving mental health counseling;
  • A history of:
  • bipolar disorder,
  • psychosis, or
  • substance abuse/dependency
  • Severe depressive symptoms or suicidality

Arms & Interventions

Problem-Solving Treatment

Experimental

Problem-Solving Treatment is a structured, yet flexible, form of cognitive-behavioral psychotherapy intended to increase problem-solving skills.

Intervention: Problem-Solving Treatment (Behavioral)

Time Management

Active Comparator

Time Management is a structured, yet flexible, intervention intended to increase creativity.

Intervention: Time Management (Behavioral)

Outcomes

Primary Outcomes

Change in Kansas City Cardiomyopathy Questionnaire

Time Frame: 1 month, 2 months, 3 months, 4 months, 5 months

The Kansas City Cardiomyopathy Questionnaire is a 23-item, self-administered instrument that quantifies physical function, symptoms (frequency, severity and recent change), social function, self-efficacy and knowledge, and quality of life.

Secondary Outcomes

  • Change in Beck Depression Inventory(1 month, 2 months, 3 months, 4 months, 5 months)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials